SPDR® MSCI Europe Health Care UCITS ETF STW FP

Equity securities may fluctuate in value in response to the activities of individual companies and general market and economic conditions.

ETFs trade like stocks, are subject to investment risk, fluctuate in market value and may trade at prices above or below the ETFs net asset value. Brokerage commissions and ETF expenses will reduce returns.

Investing in foreign domiciled securities may involve risk of capital loss from unfavorable fluctuation in currency values, withholding taxes, from differences in generally accepted accounting principles or from economic or political instability in other nations.

NAV EUR (Official NAV)
€190,88
as of 01 Dec 2022
Base Fund Currency
EUR
1 Day Nav Change
+€1,70 (+0,90%)
as of 01 Dec 2022
Assets Under Management
€530,37 M
as of 01 Dec 2022
TER
0,18%
image load fail
as of 31 Oct 2022

Fund Objective


The investment objective of the Fund is to track the performance of European large and mid-sized companies in the Health Care sector.


Index Description


The MSCI Europe Health Care 35/20 Capped Index is a free float-adjusted market capitalization weighted index that is designed to measure the equity market performance of constituents classified as Health Care (according to the Global Industry Classification Standard) in the MSCI Europe index.


Fund Information as of 03 Dec 2022

ISIN IE00BKWQ0H23
iNAV Ticker
INSTW
Inception Date 05 Dec 2014
Countries of Registration Austria, Denmark, Finland, France, Germany, Ireland, Italy, Luxembourg, Netherlands, Norway, Spain, Sweden, Switzerland, United Kingdom
Base Fund Currency EUR
Income Treatment Accumulation
Settlement Cycle Redemption Settlement Cycle, DD+2; Subscription Settlement Cycle, DD+2
Trading Cycle DD
TER 0,18%
Benchmark MSCI Europe Health Care 35/20 Capped Index
Minimum Investment 1 Share
Trading Currency CHF, EUR, GBP, MXN
UCITS Compliant Yes
Domicile Ireland
Investment Manager State Street Global Advisors Europe Limited
Sub-Investment Manager(s)

State Street Global Advisors Limited

Fund Umbrella SSGA SPDR ETFs Europe II plc
Replication Method Replicated
Distribution Frequency -
PEA Eligible No
ISA Eligible Yes
SIPP Eligible Yes
UK Reporting Status Yes
Securities Lending Yes

Listing and Ticker Information as of 03 Dec 2022

Exchange Trading Currency Listing Date Exchange Ticker SEDOL Code Bloomberg Code Reuters Code
Euronext Paris (Primary) EUR 08 Dec 2014 STW BM67JF6 STW FP STW.PA
SIX Swiss Exchange CHF 09 Dec 2014 STWX BM67JH8 STWX SE STWX.S
Deutsche Börse EUR 09 Dec 2014 SPYH BKX4075 SPYH GY SPYH.DE
London Stock Exchange EUR 09 Dec 2014 HLTH BSBNC41 HLTH LN HLTH.L
Borsa Italiana EUR 10 Dec 2014 STWX BM67JG7 STWX IM STWX.MI
Bolsa Mexicana de Valores MXN 12 Feb 2019 HLTHN BJCWGN1 HLTHN MM HLTHN.MX
London Stock Exchange GBP 04 Apr 2022 HEAE BKWQ0H2 HEAE LN HEAE.L

INAV

Estimated NAV per Unit at 4PM, Hong Kong as of
Estimated NAV per Unit as of (Updated every 15 seconds)
As of (Updated every 15 seconds)
INAV TICKER CURRENCY INAV

The Indicative NAV per share should not be viewed as the actual NAV per share. The Indicative NAV per share is provided for reference purposes only and may differ from the actual NAV per share calculated in accordance with the Prospectus.


Fund Characteristics as of 01 Dec 2022

Average Market Cap (M) €133 117,30 M
Number of Holdings 40
Average Price/Book 3,58
Price/Earnings Ratio FY1 17,06

Index Characteristics as of 01 Dec 2022

Index Dividend Yield
2,47%

Fund Market Price as of 01 Dec 2022

Bid Price €186,30
Offer Price €195,72
Closing Price €190,98
Bid/Offer Spread €9,42
Day High €190,98
Day Low €190,20
52 Week High €210,55
52 Week Low €169,78

Fund Net Asset Value as of 01 Dec 2022

NAV EUR (Official NAV) €190,88
NAV CHF CHF 187,99
NAV GBP £163,18
NAV MXN MXN $3 832,48
Assets Under Management €530,37 M
Shares in Issue 2 778 500

Reference NAVs are calculated for information purposes only. No warranty is provided as to the accuracy of reference NAVs. Reference NAVs are calculated with WM1600 FX (London time) rate applied in the currency indicated.


Fund Performance

  • Fund Inception Date: 05 Dec 2014
  • Index Inception Date: 07 May 2020
  • Performance Inception Date: 30 Sep 2001

as of 31 Oct 2022

As Of 1 Month 3 Month YTD 1 Year 3 Year 5 Year Since Inception
30 Sep 2001
Fund Net 31 Oct 2022 5,37% -6,39% -5,44% -1,97% 22,82% 48,83% 223,07%
Difference 31 Oct 2022 -0,03% -0,05% -0,05% -0,08% -0,42% -0,84% -17,60%
Fund Gross 31 Oct 2022 5,39% -6,34% -5,30% -1,79% 23,71% 50,81% 249,62%
Difference 31 Oct 2022 -0,01% 0,00% 0,09% 0,09% 0,48% 1,15% 8,95%
Index
31 Oct 2022 5,40% -6,34% -5,39% -1,88% 23,23% 49,67% 240,67%

as of 31 Oct 2022

As Of 1 Month 3 Month YTD 1 Year 3 Year 5 Year Since Inception
30 Sep 2001
Fund Net 31 Oct 2022 5,37% -6,39% -5,44% -1,97% 7,09% 8,28% 5,72%
Difference 31 Oct 2022 -0,03% -0,05% -0,05% -0,08% -0,12% -0,12% -0,27%
Fund Gross 31 Oct 2022 5,39% -6,34% -5,30% -1,79% 7,35% 8,57% 6,12%
Difference 31 Oct 2022 -0,01% 0,00% 0,09% 0,09% 0,14% 0,17% 0,13%
Index
31 Oct 2022 5,40% -6,34% -5,39% -1,88% 7,21% 8,40% 5,99%

as of 31 Oct 2022

2022 (YTD) 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
Fund Net -5,44% 25,32% -2,05% 31,62% -0,70% 2,75% -9,49% 14,77% 19,11% 25,31% 17,69%
Difference -0,05% -0,11% -0,15% -0,15% -0,12% -0,12% -0,11% -0,26% -0,17% -0,29% -0,19%
Fund Gross -5,30% 25,61% -1,76% 32,02% -0,40% 3,05% -9,22% 15,12% 19,47% 25,68% 18,04%
Difference 0,09% 0,18% 0,15% 0,24% 0,18% 0,19% 0,16% 0,09% 0,19% 0,09% 0,16%
Index
-5,39% 25,43% -1,90% 31,77% -0,58% 2,86% -9,38% 15,03% 19,28% 25,59% 17,88%

Performance Gross and Net of All Fees.

Past performance is not an indicator of future performance. The Gross of fees do not reflect and net of fees do reflect commissions and costs incurred on the issue and redemption, or purchases and sale, of units. If the performance is calculated on the basis of Gross/net asset values that are not denominated in the accounting currency of the collective investment scheme, its value may rise or fall as a result of currency fluctuations.

Calendar year inception performance returns will be partial for the year where the inception date for either the Fund in question or the historic performance-linked Fund (whichever is the earliest) falls within that period.


Deviation & Tracking Error as of 31 Oct 2022

Standard Deviation 14,64%
Tracking Error 0,15%

This calculation is based on the past 3 years performance information.


Top Holdings

Fund Top Holdings as of 01 Dec 2022

Security Name Weight
Roche Holding Ltd Dividend Right Cert. 15,57%
AstraZeneca PLC 14,13%
Novo Nordisk A/S Class B 13,90%
Novartis AG 13,03%
Sanofi 6,97%
GSK plc 4,68%
Bayer AG 3,85%
EssilorLuxottica SA 3,65%
Lonza Group AG 2,63%
Alcon AG 2,30%
Download All Holdings: Download Daily Holdings

Industry Allocation

Fund Industry Allocation as of 01 Dec 2022

Sector Weight
Pharmaceuticals 76,14%
Health Care Equipment & Supplies 12,79%
Life Sciences Tools & Services 5,60%
Biotechnology 4,01%
Health Care Providers & Services 1,46%

Geographical Weights


Characteristics, holdings and sectors shown are as of the date indicated and are subject to change. This information should not be considered a recommendation to invest in a particular sector or to buy or sell any security shown. It is not known whether the sectors or securities shown will be profitable in the future. The holdings are taken from the accounting records of SSGA which may differ from the official books and records of the custodian.

Performance Gross and Net of All Fees.

Past performance is not an indicator of future performance. The Gross of fees do not reflect and net of fees do reflect commissions and costs incurred on the issue and redemption, or purchases and sale, of units. If the performance is calculated on the basis of Gross/net asset values that are not denominated in the accounting currency of the collective investment scheme, its value may rise or fall as a result of currency fluctuations.

First net asset value taken into account corresponds to the first end of month following complete investment of the portfolio in agreement with the policy of management. Historical performance is not necessarily indicative of actual future investment performance.

The financial products referred to herein are not sponsored, endorsed, or promoted by MSCI and MSCI bears no liability with respect to any such financial products or any index on which such financial products are based. The Prospectus contains a more detailed description of the limited relationship MSCI has with SSGA and any related financial products.

Previous to 1 December 2020, this Fund's Benchmark was the MSCI Europe Health Care Index.

© 2022 Morningstar, Inc. All rights reserved. The information contained herein; (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. State Street does not review the Morningstar data.